20112019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 8 Article
  • 2 Comment/Letter to the editor

Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation

van Kempen, Z. L. E., van Rossum, J. A., Doesburg, D., Claessen, I., de Vries, A., ten Brinke, A., van Oosten, B. W., Rispens, T. & Killestein, J., 2019, In : Journal of Neurology.

Research output: Contribution to journalComment/Letter to the editorAcademic

Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient

van Rossum, J. A., Peters, M. A. D., van der Valk, P. & de Jong, B. A., 2019, In : Multiple Sclerosis and Related Disorders. 34, p. 38-40

Research output: Contribution to journalComment/Letter to the editorAcademic

gMS-Classifier1 does not predict disability progression in multiple sclerosis

van Rossum, J. A., Killestein, J., Villar, L. M., Riskind, P. N., Freedman, M. S. & Teunissen, C., 2018, In : Multiple Sclerosis Journal.

Research output: Contribution to journalArticleAcademicpeer-review

High cumulative JC virus seroconversion rate during long-term use of natalizumab

Vennegoor, A., van Rossum, J. A., Leurs, C., Wattjes, M. P., Rispens, T., Murk, J. L. A. N., Uitdehaag, B. M. J. & Killestein, J., Jun 2016, In : European Journal of Neurology. 23, 6, p. 1079-1085

Research output: Contribution to journalArticleAcademicpeer-review